GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen Spa (STU:78Q) » Definitions » Total Stockholders Equity

Philogen Spa (STU:78Q) Total Stockholders Equity : €90.59 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Philogen Spa Total Stockholders Equity?

Philogen Spa's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €90.59 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Philogen Spa's Book Value per Share for the quarter that ended in Dec. 2023 was €2.25. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Philogen Spa's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.13.

Philogen Spa Total Stockholders Equity Historical Data

The historical data trend for Philogen Spa's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Philogen Spa Total Stockholders Equity Chart

Philogen Spa Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Stockholders Equity
55.67 105.09 97.92 90.59

Philogen Spa Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial 105.09 105.92 97.92 104.84 90.59

Philogen Spa  (STU:78Q) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Philogen Spa's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(90.589-0)/40.2896
=2.25

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Philogen Spa's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1 + 11.1) / 90.589
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Philogen Spa Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Philogen Spa's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Philogen Spa (STU:78Q) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Philogen Spa (STU:78Q) » Definitions » Total Stockholders Equity
Comparable Companies
MIL:UBM MIL:ABS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB RPRX
Traded in Other Exchanges
PHIL:Italy
Address
Piazza La Lizza No. 7, Siena, ITA, 53100
Website
https://www.philogen.com
Philogen Spa is a biotechnology company. The company develops biotech products for the imaging and therapy of life-threatening diseases. Its pipeline products include Nidlegy; Fibromun; Darleukin; Dodekin; Dekavil and others. Geographically, it derives a majority of revenue from the USA.

Philogen Spa (STU:78Q) Headlines

No Headlines